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Abstract
Background: Congenic strains of mice are assumed to differ only at a single gene or region of the
genome. These mice have great importance in evaluating the function of genes. However, their
utility depends on the maintenance of this true congenic nature. Although, accumulating evidence
suggests that congenic strains suffer genetic divergence that could compromise interpretation of
experimental results, this problem is usually ignored. During coinfection studies with Salmonella
typhimurium  and Theiler's murine encephalomyelitis virus (TMEV) in major histocompatibility
complex (MHC)-congenic mice, we conducted the proper F2 controls and discovered significant
differences between these F2 animals and MHC-genotype-matched P0 and F1 animals in weight gain
and pathogen load. To systematically evaluate the apparent non-MHC differences in these mice, we
infected all three generations (P0, F1 and F2) for 5 MHC genotypes (b/b, b/q and q/q as well as d/d,
d/q, and q/q) with Salmonella and TMEV.
Results: Infected P0 MHC q/q congenic homozygotes lost significantly more weight (p = 0.02) and
had significantly higher Salmonella (p < 0.01) and TMEV (p = 0.02) titers than the infected F2 q/q
homozygotes. Neither weight nor pathogen load differences were present in sham-infected
controls.
Conclusions: These data suggest that these strains differ for genes other than those in the MHC
congenic region. The most likely explanation is that deleterious recessive mutations affecting
response to infection have accumulated in the more than 40 years that this B10.Q-H-2q MHC-
congenic strain has been separated from its B10-H-2b parental strain. During typical experiments
with congenic strains, the phenotypes of these accumulated mutations will be falsely ascribed to
the congenic gene(s). This problem likely affects any strains separated for appreciable time and
while usually ignored, can be avoided with the use of F2 segregants.
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Background
It is assumed that knockout, transgenic or other congenic
strains of mice are identical at all loci or genomic regions
except the one being studied. There are three principal
sources of genetic variation that could cause congenic
strains to diverge: 1) residual heterozygosity may remain
after the construction of the strains, 2) poor animal hus-
bandry could lead to contamination of the strains, and 3)
new mutations could become fixed in the strains. There
are documented cases in strains of mice of residual heter-
ozygosity [1], genetic contamination [2] and accumulated
mutations [3,4]. The relative importance of these three
possible sources of genetic divergence among laboratory
strains is unclear.
Appreciation of the problem of genetic divergence in
strains of inbred mice is not a new one. It has long been
expected that independently maintained strains (sub-
strains) might accumulate genetic differences over time
[5] and there are now numerous documented cases of
phenotypic divergence between substrains. For instance,
different substrains of mice respond differently with
respect to a stimulus such as cocaine [6] and in cases
involving autoimmune or infectious diseases, different
substrains of mice respond differently with proteoglycan-
induced arthritis [7], experimental allergic orchitis [8],
dextran sulfate sodium-induced colitis [9], lipopolysac-
charide (LPS) responsiveness [10] and susceptibility to
Theiler's virus-induced demyelinating disease [11].
The situation is more problematic for congenic strains
because they are expected to be phenotypically different.
Thus, when phenotypic differences are detected they are
usually attributed to the congenic region without testing
(controlling) for the possibility of genetic divergence
between strains. The longer congenic mouse strains have
been separated, the more likely they will have experienced
unintended genetic divergence, particularly from accumu-
lated mutations that can influence detectable phenotypes
and thus degrade their congenic nature [12]. The easiest
way to test for phenotypic differences that are not due to
the known congenic differences is to compare F2 animals
to their genotype matched P0 and F1 counterparts. If the
only differences are the congenic genes, then the F2 results
will match those from P0  and F1  animals. If other
unknown differences, such as accumulated mutations,
exist between these congenic strains, then F2 results will
differ from the P0 and F1 results because the unknown
genetic differences will be randomly segregating in the F2
animals. Unfortunately, the problem is usually ignored
and if present will be undetected without conducting F2
controls. Without these controls, the phenotypes due to
accumulated mutations will be falsely ascribed to the con-
genic region.
During coinfection studies designed to evaluate the role of
MHC genotypes on infection with Salmonella and a virus
that induces symptoms similar to multiple sclerosis,
Theiler's murine encephalomyelitis virus (TMEV) [13], we
conducted the F2 controls to determine if these animals
behaved differently from P0 and F1 animals with respect to
weight gain and pathogen load. We suspected they might,
because the B10 MHC congenic strains used have been
separated for greater than 40 years, enough time for many
mutations to become fixed in these strains. Since we
observed significant differences between the P0, F1 and F2
generations of mice, we completed that study with F2 ani-
mals to avoid the problem of accumulated mutations in
these lines [13].
To experimentally explore this apparent mutation accu-
mulation in the B10 MHC-congenic lines, we conducted
an additional experiment (reported here) where sham-
infected and infected P0, F1 and F2 mice were assayed for
differences in weight gain and pathogen titer in this coin-
fection model. We report significant infection-dependent
differences between generations. This study is the first
time this problem has been documented in B10 MHC-
congenic strains and suggests that deleterious recessive
mutations or other sources of genetic divergence have
destroyed the purported congenic nature of these strains.
Results
Table 1 provides the Salmonella and TMEV titers for the
infected mice. The F2 q/q homozygotes had significantly
lower Salmonella titers than the P0 q/q homozygotes for the
b and q genotypic combination (F(1,35) = 7.13, p = 0.01)
and a marginally significant trend in the d and q combi-
nation (F(1,33) = 3.02, p = 0.09). Similarly, the F2 q/q
homozygotes had significantly lower TMEV titers than the
P0 q/q homozygotes for the d and q genotypic combina-
tion (F(1,33) = 5.85, p = 0.02). The pattern was similar for
the b and q genotypic combination but the difference was
not significant.
Figure 1 illustrates the weight change for both the sham-
infected and infected d and q genotypic combination of
mice. All infected mice had retarded growth as compared
with the sham-infected mice (Figure 1, F(1,188) = 37.839,
p < 0.0001). The F2 q/q homozygotes lost significantly less
weight than the P0 q/q homozygotes (Figure 1, F(1,165) =
5.79, p = 0.02) and this was consistent with the Salmonella
and TMEV titers (Table 1). The weight-difference pattern
was similar between P0 and F2 q/q mice in the b and q gen-
otypic combination (data not shown), but it was not sig-
nificant. There was no significant difference between P0
and F2 q/q mice that were sham-infected.BMC Immunology 2004, 5:14 http://www.biomedcentral.com/1471-2172/5/14
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Discussion
In four of six comparisons, F2 q/q homozygotes did signif-
icantly better during coinfection than their P0 counter-
parts as measured by pathogen titers (Table 1) or weight
change (Figure 1). These results are consistent with the
hypothesis that deleterious recessive mutations influenc-
ing susceptibility to Salmonella  and/or TMEV infection
have accumulated in this B10.Q MHC congenic strain.
This conclusion is not too surprising, given that these
MHC-congenic strains have been separated for more than
40 years and recent experiments [14] and theory [15] have
shown that important mutations can accumulate in a
small number of generations. In addition, the effective
population size of the breeding colonies at The Jackson
Laboratory is usually about 24 individuals (12 foundation
breeding pairs, Jennifer Merriam, The Jackson Laboratory,
personal communication), causing drift to be a powerful
factor in the fixation of deleterious mutations [16]. This is
the first study to identify infection-dependent phenotypes
in MHC-congenic strains that are not due to genes within
the MHC congenic region. Many studies have identified
infection-dependent phenotypes between MHC-congenic
strains ([13], and references therein), but none of those
studies tested whether the phenotype segregates with the
congenic region by testing F2 segregants.
Since F2 q/q mice lose less weight (Figure 1) and show a
decrease in pathogen load relative to P0 q/q mice (Table 1),
these data suggest that the observed genetic divergence is
due to the accumulation of deleterious recessive muta-
tions, rather than genetic contamination or residual heter-
ozygosity. We make this interpretation because among the
three possible sources of genetic divergence, only random
mutations are usually expected to be deleterious recessive.
Predictions can be made about how accumulated reces-
sive deleterious mutations will be expressed in each gen-
eration. Homozygous P0  will express all deleterious
recessive mutations while the F1 heterozygotes will experi-
ence hybrid vigor (or heterosis) because the inherited
recessive deleterious mutations will not be in a
homozygous state and the defective phenotypes will be
masked. In F2 segregants, the inheritance of any recessive
mutations will be randomized such that some mutations
will be expressed (in a homozygous state) and some
mutations will not be expressed (in a heterozygous state).
Thus, if recessive deleterious mutations are present, the F2
segregants should show an increase in weight gain and a
decrease in pathogen titers compared to the P0 mice, as
was generally observed in this study. The F2 segregants
might have a higher variance, but because the expression
of deleterious recessive mutations is randomized, it will
still be possible to evaluate the phenotype of the congenic
gene(s). Thus, using congenic F2 segregants should elimi-
nate any bias caused by accumulated mutations [17],
except those linked to the congenic region.
The fixation of deleterious mutations causing infection-
dependent susceptibilities (as we observed in weight
change, Figure 1), would be expected to occur dispropor-
tionately in animal strains housed in "clean" (pathogen
free) colonies. Mutational defects that are infection-
dependent should accumulate in pathogen free colonies
because they carry little to no cost in the absence of infec-
tions. Because most, if not all, inbred mice have been
housed in pathogen free colonies for numerous years, this
predicts that infection-dependent differences between
strains might accumulate at higher rates than other muta-
tional defects.
Table 1: Average Salmonella and TMEV titers (+/- SE) for female P0, F1 and F2 mice.
Generation Sample Size MHC Genotype Salmonella titers (102 CFU/spleen) TMEV titers (102 PFU/spcd)
P0 6 b/b 51.93 +/- 6.60 1.33 +/- 1.09
F1 8 b/q 6.60 +/- 0.83 0.97 +/- 0.41
P0 7 q/q 13.09 +/- 3.27a 126.75 +/- 32.75
F2 7 b/b 140.49 +/- 38.87 4.00 +/- 2.63
F2 7 b/q 6.34 +/- 1.58 3.21 +/- 1.99
F2 6 q/q 5.67 +/- 2.00a 52.08 +/- 16.63
P0 7 d/d 10.57 +/- 1.21 4.29 +/- 3.55
F1 7 d/q 7.23 +/- 1.80 11.25 +/- 6.04
P0 6 q/q 10.53 +/- 3.60c 331.92 +/- 180.16b
F2 4 d/d 9.05 +/- 1.19 3.81 +/- 3.40
F2 10 d/q 14.00 +/- 4.11 6.15 +/- 1.76
F2 5 q/q 4.16 +/- 0.85c 13.65 +/- 8.98b
spcd = spinal cord; Comparisons in bold are significantly different as follows: a (F(1,35) = 7.127, p = 0.01); b (F(1,33) = 5.84, p = 0.02); c marginally 
significant (F(1,33) = 3.02, p = 0.09).BMC Immunology 2004, 5:14 http://www.biomedcentral.com/1471-2172/5/14
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Residual weight change (+/- SE) between sham-infected (a) and coinfected (b) P0, F1 and F2 female mice Figure 1
Residual weight change (+/- SE) between sham-infected (a) and coinfected (b) P0, F1 and F2 female mice. Sample 
sizes are indicated above each bar. All p values are from an ANOVA with simple comparisons.
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The ability to detect mutation accumulation is easier in
substrains that are purportedly identical than among con-
genic strains. This is because substrains are expected to
express identical phenotypes and when differences are
detected they are usually interpreted as due to mutational
divergence. In contrast, when differences are detected
among congenic strains, the typical interpretation is that
the congenic region caused these differences. Unfortu-
nately, the differences could be due to accumulated muta-
tions [3,4], residual heterozygosity [1] or genetic
contamination [2] of the congenic strain. There is no way
to discriminate between phenotypes due to the congenic
region from those due to genetic divergence without addi-
tional experiments, such as conducting F2 controls, but
these additional experiments are almost never done. One
must be suspicious of the 33 phenotypes that have been
ascribed to MHC genes [18], many of which have nothing
to do with immune recognition. We suggest that many of
these phenotypes are due to accumulated mutations or
genetic divergence.
Because MHC congenic strains are among the oldest of
congenic strains, they have been tested for many pheno-
types over the years. One recent example involves the
claim that an "electronic nose" could detect odor differ-
ences between MHC mutational congenic strain bm1 and
the parental B6 that differs by only 3 mutations in a class
I binding site [19]. This study did not use F2 controls. A
subsequent study using an odor detection assay with mice
confirmed that these two congenic strains did have odor
differences detectable by mice, but these differences disap-
peared when F2 animals were tested [20]. This olfaction
study further supports the conclusions of this paper that
these B10 congenic strains have diverged genetically caus-
ing phenotypic differences not due to the MHC congenic
region.
Conclusions
Any strain separated by appreciable amounts of time will
invariably accumulate mutational differences and this
study demonstrates that these accumulated mutational
differences can be important. For congenic strains, these
mutational differences will be falsely ascribed to the con-
genic region when comparing pure strains. While we only
have evidence for mutation accumulation in the q/q con-
genic strains, it is unlikely that other congenic strains have
not accumulated mutations. This problem is widely
ignored. Re-deriving the strains frequently or using F2 seg-
regants can solve this problem. Unfortunately, both rem-
edies are time-consuming and expensive, particularly re-
deriving the strains.
Methods
Mice
MHC congenic mice (C57BL/10SnJ-H2b, B10.D2-H2d H2-
T18cHc1/nSnJ and B10.Q-H2q/SgJ) were obtained from
The Jackson Laboratory (Bar Harbor, ME) and bred there-
after under specific pathogen free conditions. P0 homozy-
gotes were bred to produce F1 heterozygote offspring.
These F1 mice were then intercrossed to produce the F2 seg-
regants. P0, F1 and F2 mice were either sham-infected with
phosphate buffered saline (PBS) or infected with Salmo-
nella enterica (serovar Typhimurium, strain C5TS) and the
Daniels' (DA) strain of TMEV.
To control for potential heterosis, only F2  segregants
derived from the F1 heterozygotes were used in the exper-
iment. To control for potential variation among cages,
age-matched mice were housed by sex, in groups of six
individuals representing the three genotypes to be com-
pared (e.g. b/b, b/q and q/q or d/d, d/q and q/q) from both
the F2 and P0 or F1 generation. All q/q mice were analyzed
according to their housing conditions and thus not
pooled for analysis (e.g. q/q mice housed with b/b and b/q
mice were analyzed only with the b and q haplotypic com-
bination). All cagemates were unrelated (progeny of dif-
ferent parents) and had not been previously housed
together when infected. Mice were MHC-genotyped at two
microsatellite loci within the MHC region (a tetranucle-
otide repeat [21] and d17Mit34 [22]) using PCR for DNA
amplification and denaturing gel electrophoresis for scor-
ing band size.
Weights
Mice infected with Salmonella or TMEV display noticeable
weight loss that is usually correlated with disease symp-
toms. Thus, mice were weighed three times per week. The
following regression equations were based on sham-
infected weights and take into account the starting weight
and age of the mice. These equations were used to calcu-
late the residual weight change in order to control for 1–2
week differences in the starting ages of the mice. For
female mice, residual weight change = 34.3065–
1.5151(Age) + 0.0221(Age)2 – 0.00009(Age)3. 
Parameters of infection
Four-to seven-week-old mice were anesthetized with
metofane (methoxyflurane) and simultaneously infected
retro-orbitally with 1 × 106 CFU/ml of the C5TS strain of
Salmonella and intra-cerebrally with 2 × 105 PFU/ml of the
DA strain of Theiler's virus or sham-infected as above with
PBS. The C5TS strain is a temperature-sensitive mutant
strain of Salmonella [23] that causes a chronic, non-fatal
infection. The overnight culture of Salmonella was washed
twice with PBS to remove any excess LPS on the surface of
the bacteria before mice were infected.BMC Immunology 2004, 5:14 http://www.biomedcentral.com/1471-2172/5/14
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Salmonella titers
Mice were sacrificed four weeks post-infection. Salmonella
titers were assayed from platings of homogenized spleen.
Briefly, spleens were collected under antiseptic condi-
tions, immediately homogenized and plated on Shigella-
Salmonella (SS) agar, which was then incubated overnight
at 30°C. When this strain was created in the early 1970s
[23] with an UV screen, the authors found that a small
(unspecified) percentage reverted back to the wild-type
C5 virulent strain. To check for possible wild-type rever-
tants, spleen homogenates were also plated on SS agar
and incubated overnight at 37°C. If more than 50% of the
colonies of an infected mouse also grew at 37°C, then the
infection was deemed to be dominated by a revertant and
the data point was excluded on the basis that the revertant
was more lethal (i.e. faster replication rate than C5TS).
Only one animal contained <50% revertants. A total of 58
animals (out of 228) were excluded either because they
died, were sacrificed prior to 28 days or contained Salmo-
nella revertants. Of the 58 excluded mice, 13 (22%) died,
33 (57%) were sacrificed prior to 28 days due to severe ill-
ness and 12 (21%) contained revertants. Of the 33 mice
that were sacrificed early, 21 (63%) contained revertants.
Theiler's virus titers
TMEV titers were assayed by conducting viral plaque
assays on brain and spinal cord homogenates [24].
Briefly, brain and spinal cords were collected and stored in
0.5 ml TMEV diluent (PBS, 1% antibiotics, 1% fetal calf
serum) at -70°C until assayed. Brain and spinal cords
were homogenized and frozen/thawed twice. Samples
were then centrifuged at 450 g for 10 minutes and the
supernate collected. Supernatant fluid was then added to
baby hamster kidney (BHK) -21 cells and incubated for
one hour at 37°C, hand rocking every 10–15 minutes.
Fluid was then aspirated off the BHK cells and a 1:1 mix-
ture of 1% agarose: 2X 199 Medium was added to the
wells. Plates were incubated at 37°C for 4 days before fix-
ation with 2.5% formalin, followed by staining with 0.1%
crystal violet and enumeration of plaques.
Statistics
An analysis of variance (ANOVA) was used to test for
weight differences between MHC genotype and genera-
tion (P0, F1 versus F2) while a multivariate analysis of var-
iance (MANOVA) was used to test for pathogen load
differences between MHC genotype and generation (P0, F1
versus F2). Because an increase in type I error is controlled
for by use of a MANOVA, this was followed by univariate
analyses for each pathogen for each genotypic combina-
tion. Where needed, simple contrasts were then done to
determine which genotype(s) was responsible for the
effect.
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